Search Results
Search for other papers by Lauren N Pontius in
Google Scholar
PubMed
Search for other papers by Linda M Youngwirth in
Google Scholar
PubMed
Search for other papers by Samantha M Thomas in
Google Scholar
PubMed
Search for other papers by Randall P Scheri in
Google Scholar
PubMed
Search for other papers by Sanziana A Roman in
Google Scholar
PubMed
Search for other papers by Julie A Sosa in
Google Scholar
PubMed
institution, and comorbidity score. Annual income levels were assigned by the NCDB by linking a patient’s zip code to the U.S. Census data for the year 2000. Comorbidity was represented by the modified Charlson/Deyo scoring system ( Deyo et al. 1992
Cancer Genetics, Department of Surgery, Anatomical Pathology, Endocrinology, Endocrine and Oncology Surgery, Kolling Institute of Medical Research, Royal North Shore Hospital, University of Sydney, St Leonards, Sydney, New South Wales 2065, Australia
Search for other papers by P S H Soon in
Google Scholar
PubMed
Search for other papers by A J Gill in
Google Scholar
PubMed
Search for other papers by D E Benn in
Google Scholar
PubMed
Search for other papers by A Clarkson in
Google Scholar
PubMed
Cancer Genetics, Department of Surgery, Anatomical Pathology, Endocrinology, Endocrine and Oncology Surgery, Kolling Institute of Medical Research, Royal North Shore Hospital, University of Sydney, St Leonards, Sydney, New South Wales 2065, Australia
Search for other papers by B G Robinson in
Google Scholar
PubMed
Search for other papers by K L McDonald in
Google Scholar
PubMed
Cancer Genetics, Department of Surgery, Anatomical Pathology, Endocrinology, Endocrine and Oncology Surgery, Kolling Institute of Medical Research, Royal North Shore Hospital, University of Sydney, St Leonards, Sydney, New South Wales 2065, Australia
Search for other papers by S B Sidhu in
Google Scholar
PubMed
) can be difficult. The Weiss score, a nine-point histopathological scoring system, is presently the most widely used system for classifying adrenocortical tumors (ACTs) as benign or malignant. A total score of ≤2 is typically associated with a benign
Search for other papers by Bertrand Brieau in
Google Scholar
PubMed
Search for other papers by Olivia Hentic in
Google Scholar
PubMed
Search for other papers by Rachida Lebtahi in
Google Scholar
PubMed
Search for other papers by Maxime Palazzo in
Google Scholar
PubMed
Search for other papers by Makrem Ben Reguiga in
Google Scholar
PubMed
Search for other papers by Vinciane Rebours in
Google Scholar
PubMed
Search for other papers by Frederique Maire in
Google Scholar
PubMed
Search for other papers by Pascal Hammel in
Google Scholar
PubMed
Search for other papers by Philippe Ruszniewski in
Google Scholar
PubMed
Search for other papers by Pierre Fenaux in
Google Scholar
PubMed
, . 2015 Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in
Department of Cardiology, Department of Obesity and Endocrinology, Clinical Sciences Centre, University Hospital Aintree, Lower Lane, Liverpool L9 7AL, UK
Search for other papers by Rebecca Dobson in
Google Scholar
PubMed
Search for other papers by Daniel J Cuthbertson in
Google Scholar
PubMed
Search for other papers by Malcolm I Burgess in
Google Scholar
PubMed
( Pellikka et al . 1993 ), there is no current consensus on how to most accurately define and quantify carcinoid heart disease. This has led to several different echocardiographic scoring systems being developed to describe the disease, which have been used
Search for other papers by Mouna Tabebi in
Google Scholar
PubMed
Clinical Genomics Linköping, Linköping University, Linköping, Sweden
Search for other papers by Peter Söderkvist in
Google Scholar
PubMed
Department of Surgery, Linköping University, Linköping, Sweden
Search for other papers by Oliver Gimm in
Google Scholar
PubMed
PPGLs are considered to be malignant and metastasize, the currently existing tools to predict which ones are insufficient. Several histopathologic scoring systems have been proposed and in 2002, Thompson developed the first pathology scoring system, PCC
Search for other papers by Arthur S Tischler in
Google Scholar
PubMed
Department of Pathology and Laboratory Medicine, Department of Pathology, Department of Pathology, Tufts Medical Center, Tufts University School of Medicine, 800 Washington Street, Box 802, Boston, Massachusetts 02111, USA
Search for other papers by Ronald R deKrijger in
Google Scholar
PubMed
individual findings have been sufficiently reliable to allow a tumor to be confidently dismissed as benign. Attempts have therefore been made to develop multiparameter scoring systems for risk stratification. A seminal study of pheochromocytomas and
Search for other papers by S G Creemers in
Google Scholar
PubMed
Search for other papers by P M van Koetsveld in
Google Scholar
PubMed
Search for other papers by F J van Kemenade in
Google Scholar
PubMed
Department of Histopathology, King’s College Hospital, Denmark Hill, London, UK
Search for other papers by T G Papathomas in
Google Scholar
PubMed
Search for other papers by G J H Franssen in
Google Scholar
PubMed
Search for other papers by F Dogan in
Google Scholar
PubMed
Search for other papers by E M W Eekhoff in
Google Scholar
PubMed
Search for other papers by P van der Valk in
Google Scholar
PubMed
Search for other papers by W W de Herder in
Google Scholar
PubMed
Search for other papers by J A M J L Janssen in
Google Scholar
PubMed
Search for other papers by R A Feelders in
Google Scholar
PubMed
Search for other papers by L J Hofland in
Google Scholar
PubMed
surgery ( Lacroix 2010 ). However, the discrimination of ACCs from adrenocortical adenomas (ACAs) still remains challenging on both imaging and postoperative histopathological grounds. The current pathological scoring system (Weiss score) is limited by a
Division of Environmental Genetics and Molecular Toxicology, Division of Epidemiology and Biostatistics, Center for Environmental Genetics, Cancer Center, Department of Pathology, Department of Pathology and Laboratory Medicine, Department of Environmental Health
Division of Environmental Genetics and Molecular Toxicology, Division of Epidemiology and Biostatistics, Center for Environmental Genetics, Cancer Center, Department of Pathology, Department of Pathology and Laboratory Medicine, Department of Environmental Health
Search for other papers by Yuet-Kin Leung in
Google Scholar
PubMed
Search for other papers by Hung-Ming Lam in
Google Scholar
PubMed
Search for other papers by Shulin Wu in
Google Scholar
PubMed
Search for other papers by Dan Song in
Google Scholar
PubMed
Search for other papers by Linda Levin in
Google Scholar
PubMed
Search for other papers by Liang Cheng in
Google Scholar
PubMed
Search for other papers by Chin-Lee Wu in
Google Scholar
PubMed
Division of Environmental Genetics and Molecular Toxicology, Division of Epidemiology and Biostatistics, Center for Environmental Genetics, Cancer Center, Department of Pathology, Department of Pathology and Laboratory Medicine, Department of Environmental Health
Division of Environmental Genetics and Molecular Toxicology, Division of Epidemiology and Biostatistics, Center for Environmental Genetics, Cancer Center, Department of Pathology, Department of Pathology and Laboratory Medicine, Department of Environmental Health
Search for other papers by Shuk-Mei Ho in
Google Scholar
PubMed
cytoplasmic signals of each ERβ isoform were examined separately. Signal intensity and percentage of signal coverage of each region were scored according to the Allred scoring system ( Allred et al . 1993 ). The intensity signal was graded from 0 to 3 (0
Search for other papers by Noriko Kimura in
Google Scholar
PubMed
Search for other papers by Ryoichi Takayanagi in
Google Scholar
PubMed
Search for other papers by Nae Takizawa in
Google Scholar
PubMed
Search for other papers by Eiji Itagaki in
Google Scholar
PubMed
Search for other papers by Takayuki Katabami in
Google Scholar
PubMed
Search for other papers by Narihiko Kakoi in
Google Scholar
PubMed
Search for other papers by Hiromi Rakugi in
Google Scholar
PubMed
Search for other papers by Yukihiro Ikeda in
Google Scholar
PubMed
Search for other papers by Akiyo Tanabe in
Google Scholar
PubMed
Search for other papers by Takeshi Nigawara in
Google Scholar
PubMed
Search for other papers by Sadayoshi Ito in
Google Scholar
PubMed
Search for other papers by Itaru Kimura in
Google Scholar
PubMed
Search for other papers by Mitsuhide Naruse in
Google Scholar
PubMed
Search for other papers by The Phaeochromocytoma Study Group in Japan in
Google Scholar
PubMed
confluent (comedo-type) tumour necrosis ( Zelinka et al . 2011 ), have been used in previous studies ( Kimura & Sasano 1990 , Linnoila et al . 1990 , Unger et al . 1991 ). Such features have been combined in a scoring system named the Phaeochromocytoma
Search for other papers by G Riesco-Eizaguirre in
Google Scholar
PubMed
Search for other papers by P Gutiérrez-Martínez in
Google Scholar
PubMed
Search for other papers by M A García-Cabezas in
Google Scholar
PubMed
Search for other papers by M Nistal in
Google Scholar
PubMed
Search for other papers by P Santisteban in
Google Scholar
PubMed
well-established prognostic factors can help to ascertain the most appropriate treatment and follow-up for these patients. Several prognostic scoring systems, such as the tumour node metastasis (TNM) classification ( American Joint Committee on Cancer